This is a press release today about the treatment used in Germany to fight prostate cancer. I did some looking around the web and found one site at the image below that gives a few additional details here and is a center in Germany using the the procedure developed by Dr. Douwes.
Their standard cancer protocol is a week of detoxification and the strengthening of the immune system with diet and nutritional supplements, followed by two weeks of localized hyperthermia treatment and low-dose chemotherapy.
In addition to conventional medicine (surgery, radiotherapy and chemotherapy) they offer nutritional supplements, detoxification, biological/nontoxic treatments that include phytotherapy, mistletoe, hormones, cytokines, biological response modifiers, immune therapy, hyperthermia, Galvanotherapy, and psychological therapies including group therapy, guided imagery and art therapy.
The treatment is not used in the US and the article states that many have traveled to Germany for the procedure as it is non invasive. The press releases cites a couple stories from those who have been treated at the facility. Dr. Douwes spent his internship here in the US in Philadelphia and then returned to Germany. BD
SARASOTA, Fla., April 15 /PRNewswire/ -- During a routine physical in September 2006, retired airline pilot Jeff Albulet's doctor thought he 'felt something' when he did a digital rectal exam, although Jeff's prostate specific antigen (PSA) was only 2. Six months later, Jeff's PSA rose to 3.5, and a biopsy showed pre-cancerous cells. In discussing his options with his primary care physician, he learned about a treatment that would save his prostate and not cause impotence or incontinence. According the Dr. Friedrich Douwes, Medical Director of St. George Hospital in Bad Aibling, Germany, president of the German Oncological Society and the author of several hundred scientific articles and books, trans-urethral prostate hyperthermia has a 100% initial response rate.
Albulet's doctor had heard Douwes speak at a medical conference in Las Vegas, NV. Douwes helped to develop the Oncotherm radio-wave hyperthermia treatment, which heats the entire prostate without harming healthy tissue. He has successfully treated thousands of prostate cancer patients, many from the USA. In use for over 25 years, radio-wave hyperthermia is the treatment of choice in Europe for many cancers. When Albulet learned that the treatment took only one week and had a dramatic success rate without side effects, he was elated.
In this treatment, a small probe is introduced through the urethra into the prostate. Radio frequencies are pulsed into the prostate, heating the cancer cells to between 113 and 158 degrees. Because cancer cells have a different blood supply than normal cells, they either die or become so damaged from the heat they can no longer reproduce. Normal cells are not affected. This treatment is non-surgical, so no pain medications are needed and only local anesthesia is required. And there are no side effects. Patients stay in the hospital for five days, and receive two trans-urethral treatments during that time, along with limited hormone modulation and other non-toxic medications.
According to Douwes, this treatment combined with a temporary androgen blockade is 100% effective. The ten year disease-free survival rate is 80%. The 20% of patients who have a PSA relapse in three to five years after the initial treatment can simply repeat the treatment for longer lasting good results.